A SpaceX Dragon capsule that brought supplies to the International Space Station has splashed down as planned in the Pacific Ocean. SpaceX announced on Twitter that the Dragon hit the water off the California coast shortly after 5 a.m. After being released by the space station's robotic arm, the capsule completed a 5½-hour journey back to Earth, part of which was captured by NASA astronaut Jack Fischer. NASA astronaut Jack Fischer photographed the SpaceX Dragon capsule as it reentered Earth's atmosphere before splashing down in the Pacific Ocean west of Baja California at 8:12 a.m. EDT, July 3, 2017. He photographed the SpaceX Dragon capsule as it reentered Earth's atmosphere before splashing down in the Pacific Ocean west of Baja California.

On Monday, Elon Musk's SpaceX became the first to re-fly a cargo spacecraft to the International Space Station and back, according to Space.com. A SpaceX Falcon 9 rocket, with a Dragon spacecraft onboard, left Earth on June 3, carrying over 4,100 pounds of cargo to the International Space Station. It successfully landed in the Pacific Ocean, southwest of the California coast on Monday morning at 8:14 a.m. SpaceX planned to take the spacecraft back to Long Beach, California after it landed, remove important cargo and send it to Houston, Texas for NASA analysis, according to a NASA blog post. Afterward, Dragon would return to a SpaceX test facility in McGregor, Texas.

A British hospital trust misused patient data when it shared information with Google for work on a smartphone app, a British data protection watchdog said on Monday. The Royal Free NHS Trust did not comply with the Data Protection Act when it passed on personal information of around 1.6 million patients to Google's DeepMind. DeepMind, which is owned by Alphabet, the parent company of Google, is the company's artificial intelligence and machine learning branch. The Information Commissioner's Office (ICO) said it found'a number of shortcomings' in the way the data was handled, including that patients were not adequately informed their data would be used as part of the test. A British hospital trust misused patient data when it shared information with Google's DeepMind for work on a smartphone app, a British data protection watchdog has found.

An NHS Trust broke the law by sharing sensitive patient records with Google's DeepMind division, the UK's data watchdog has ruled. The long-awaited decision falls in line with the conclusion drawn by Dame Fiona Caldicott, the UK's National Data Guardian in May. The pair's agreement "failed to comply" with the Data Protection Act 1998, according to the Information Commissioner's Office (ICO), because patients weren't informed that their information was being used. The ICO also took issue with the size of the dataset -- 1.6 million partial patient records -- leveraged by DeepMind to test Streams, an app for detecting acute kidney injury. In April 2016, New Scientist revealed that DeepMind and Royal Free London NHS Trust were working together on a medical project. As the ICO notes in its letter to the Trust, their agreement was actually formalised in September 2015, with Royal Free serving as the data controller (owner) and DeepMind as the data processor (partner).

The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new USD 43 million deal in the field on Sunday. Other pharmaceutical giants including Merck & Co, Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence (AI) to help streamline the drug discovery process. The aim is to harness modern supercomputers and machine learning systems to predict how molecules will behave and how likely they are to make a useful drug, thereby saving time and money on unnecessary tests. AI systems already play a central role in other high-tech areas such as the development of driverless cars and facial recognition software. "Many large pharma companies are starting to realise the potential of this approach and how it can help improve efficiencies," said Andrew Hopkins, chief executive of privately owned Exscientia, which announced the new tie-up with GSK. Hopkins, who used to work at Pfizer, said Exscientia's AI system could deliver drug candidates in roughly one-quarter of the time and at one-quarter of the cost of traditional approaches.

A UK hospital did not do enough to protect the privacy of patients when it shared data with Google, the UK's Information Commission (ICO) has ruled. The ICO censured the Royal Free NHS Foundation Trust about data handed over during trials of a novel way to detect kidney injuries. Among other failings, the ICO said the hospital did not tell patients enough about the way their data was used. The trust said it would tackle "shortcomings" in its data-handling. Details on about 1.6 million patients was provided to Google's DeepMind division during the early stages of the medical trial last year.

The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline PLC unveiling a new $43-million (U.S.) deal in the field on Sunday. Other pharmaceutical giants including Merck & Co. Inc.,Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence to help streamline the drug discovery process. The aim is to harness modern supercomputers and machine learning systems to predict how molecules will behave and how likely they are to make a useful drug, thereby saving time and money on unnecessary tests. AI systems already play a central role in other high-tech areas such as the development of driverless cars and facial-recognition software. "Many large pharma companies are starting to realize the potential of this approach and how it can help improve efficiencies," said Andrew Hopkins, chief executive of privately owned Exscientia, which announced the new tie-up with GSK. Mr. Hopkins, who used to work at Pfizer, said Exscientia's AI system could deliver drug candidates in roughly one-quarter of the time and at one-quarter of the cost of traditional approaches.

It might resemble something out of Star Wars, but this is the prototype for a combat suit that Russia hopes will give its soldiers the edge on the battlefields of the future. The high-tech item includes an exo-skeleton, or outer layer, designed to boost strength and stamina and a layer of body armour to shield the wearer from bullets. The all-black kit also has a Stormtrooper-style helmet with a tinted glass visor and a mini task light poking out of the side. The high-tech item includes an exo-skeleton, or outer layer, designed to boost strength and stamina. It was put on display on Thursday at the National University of Science and Technology in Moscow.

A SpaceX Dragon capsule that brought supplies to the International Space Station has splashed down as planned in the Pacific Ocean. SpaceX announced on Twitter that the Dragon hit the water off the California coast shortly after 5 a.m. After being released by the space station's robotic arm, the capsule completed a 5½-hour journey back to Earth. SpaceX will recover the spacecraft and take it back to California. Cargo from the space station will be sent to NASA for analysis.

Theresa May's plans for an internet crackdown are like a Chinese dictator, according to her own policy watchdog. The government's plans to fine technology companies if they fail to remove extremist material are a challenge to democracy, according to Max Hill, QC – the new independent reviewer of counterterrorism legislation. The fines are just one part of the Conservatives' wide-ranging plans to regulate and censor the internet, which they claim will help reduce terror. Those plans were laid out in the party's manifesto before the election, and the prime minister has committed to push forward with them despite not winning a majority in the election. The I.F.O. is fuelled by eight electric engines, which is able to push the flying object to an estimated top speed of about 120mph.